Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study Article

de Groot, John F, Lamborn, Kathleen R, Chang, Susan M et al. (2011). Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study . JOURNAL OF CLINICAL ONCOLOGY, 29(19), 2689-2695. 10.1200/JCO.2010.34.1636

Open Access

cited authors

  • de Groot, John F; Lamborn, Kathleen R; Chang, Susan M; Gilbert, Mark R; Cloughesy, Timothy F; Aldape, Kenneth; Yao, Jun; Jackson, Edward F; Lieberman, Frank; Robins, H Ian; Mehta, Minesh P; Lassman, Andrew B; DeAngelis, Lisa M; Yung, WK Alfred; Chen, Alice; Prados, Michael D; Wen, Patrick Y

sustainable development goals

authors

publication date

  • July 1, 2011

webpage

published in

keywords

  • ANGIOGENESIS
  • BEVACIZUMAB
  • ENDOTHELIAL GROWTH-FACTOR
  • EXPRESSION
  • GLIOBLASTOMA-MULTIFORME
  • INHIBITOR
  • IRINOTECAN
  • Life Sciences & Biomedicine
  • Oncology
  • SAMPLES
  • Science & Technology
  • THERAPY
  • VEGF TRAP

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 2689

end page

  • 2695

volume

  • 29

issue

  • 19